Quarterly report · Q2
9989.TEDINET S100SAP5
Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥371.7bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥690.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥339.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥20.6bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥18.5bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥21.0bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥38.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥18.8bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥20.6bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥18.5bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥14.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥25.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥12.7bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥14.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥12.7bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥369.9bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥360.7bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥337.1bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥125.2bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥124.3bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥244.7bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥236.3bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥229.1bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥76.8bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥80.9bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥76.8bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥80.9bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥94.5bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥89.3bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥23.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥37.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥21.4bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥21.7bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥28.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥12.0bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥5.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥17.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥4.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥120.2 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.18 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥219.83 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥108.81 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥54.94 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥219.82 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥108.81 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 66.1% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.5% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.0% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥26.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥26.1bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥155.0bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥155.0bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥5m |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥7.5bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥242.8bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥216.7bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥26.1bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥13.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥397.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥371.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥26.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥20.6bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥24.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥24.7bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥143.9bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥143.9bn |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥5m |
| jpcrp040300-q2r_E03226-000Discount Storereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥6.7bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥220.0bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥195.3bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥24.7bn |
| jpcrp040300-q2r_E03226-000Drug Storereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥11.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥363.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥339.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥24.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥18.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 479
| Item | Context | Value | Unit |
|---|---|---|---|
| Payments of loans receivable inv cf | Prior1YTDDuration | -126000000 | JPY |
| Payments of loans receivable inv cf | CurrentYTDDuration | -182000000 | JPY |
| Collection of loans receivable inv cf | Prior1YTDDuration | 3000000 | JPY |
| Collection of loans receivable inv cf | CurrentYTDDuration | － | JPY |
| Payments for lease and guarantee deposits inv cf | Prior1YTDDuration | -503000000 | JPY |
| Payments for lease and guarantee deposits inv cf | CurrentYTDDuration | -154000000 | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | Prior1YTDDuration | 558000000 | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | CurrentYTDDuration | 231000000 | JPY |
| Other net inv cf | Prior1YTDDuration | -967000000 | JPY |
| Other net inv cf | CurrentYTDDuration | -543000000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -12048000000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -21718000000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -4208000000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -5845000000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -0 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -0 | JPY |
| Proceeds from exercise of stock option fin cf | Prior1YTDDuration | － | JPY |
| Proceeds from exercise of stock option fin cf | CurrentYTDDuration | 83000000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -4208000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -5762000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 5153000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -4066000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 89330000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 80872000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 94484000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 76806000000 | JPY |
| Salaries allowances and bonuses sga | Prior1YTDDuration | 23972000000 | JPY |
| Salaries allowances and bonuses sga | CurrentYTDDuration | 26809000000 | JPY |
| Rent expenses sga | Prior1YTDDuration | 14226000000 | JPY |
| Rent expenses sga | CurrentYTDDuration | 15469000000 | JPY |
| Provision for directors bonuses sga | Prior1YTDDuration | 41000000 | JPY |
| Provision for directors bonuses sga | CurrentYTDDuration | 41000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 317000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 331000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E03226-000DrugStoreReportableSegmentsMember | 195297000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E03226-000DiscountStoreReportableSegmentsMember | 143925000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 339223000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 339223000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E03226-000DrugStoreReportableSegmentsMember | 24655000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E03226-000DiscountStoreReportableSegmentsMember | 5000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 24661000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -24661000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E03226-000DrugStoreReportableSegmentsMember | 219953000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E03226-000DiscountStoreReportableSegmentsMember | 143931000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 363884000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -24661000000 | JPY |
| Net sales | Prior1YTDDuration | 339223000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E03226-000DrugStoreReportableSegmentsMember | 11806000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |